Article
Identifying of selective agonists targeting LXRβ from terpene compounds of Alismatis Rhizoma
2021-02-01
Abstract excerpt
Hyperlipidemia is thought as an important contributor to coronary disease, diabetes and fatty liver. Liver X receptors β (LXRβ) was considered as a validated target for hyperlipidemia therapy due to its role in regulating cholesterol homeostasis and immunity. However, many current drugs applied in clinic are not selectively targeting LXRβ and they can also activate LXRα which activate SREBP-1c worked as activator...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ba8be4c2-928e-57e9-83e7-faf05720b1c3
- DOI
- 10.21203/rs.3.rs-164666/v1
